Our engagement unfolded in three structured phases, designed to build confidence and deliver precise, actionable recommendations:

‍

Foundation: Hypothesis Development & Initial Market Sizing

• Desk research to develop a preliminary market model, integrating data on disease prevalence, reimbursement trends, and prescription patterns per condition.
• Partnered with client stakeholders to refine assumptions and shortlist panels based on strategic alignment and technical feasibility.

 Validation: Expert Insights to Stress-Test Assumptions

• Interviewed medical professionals across key markets to confirm clinical demand, identify adoption barriers, and assess practical use cases.
•  Refined market-sizing estimates, focusing on high-potential panels with attractive market share.

Confirmation: Survey-Driven Insights for Final Prioritization (one panel)

Designed and executed a quantitative survey of 100 clinicians across five markets to evaluate adoption intent, drivers and barrier, quantitatively verify the qualitative assumptions obtained from external and expert interviews